FABP5 regulates lipid metabolism to facilitate pancreatic neuroendocrine neoplasms progression via FASN mediated Wnt/β‐catenin pathway
Cancer Science · 2023-09 · 114 (9) · 3553-3567
DOI: 10.1111/cas.15883 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Science, online erschienen am 11.06.2023. Verfasst von Feiyu Lu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatric Gastroenterology, Neuroendocrine Tumor Center, Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical Un…. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Neuroendocrine Tumors. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Science Foundation Project of Ili & Jiangsu Joint Institute of Health.
Abstract (Originalsprache)
Pancreatic neuroendocrine neoplasms (pNENs) are among the most frequently occurring neuroendocrine neoplasms (NENs) and require targeted therapy. High levels of fatty acid binding protein 5 (FABP5) are involved in tumor progression, but its role in pNENs remains unclear. We investigated the mRNA and protein levels of FABP5 in pNEN tissues and cell lines and found them to be upregulated. We evaluated changes in cell proliferation using CCK‐8, colony formation, and 5‐ethynyl‐2′‐deoxyuridine assays and examined the effects on cell migration and invasion using transwell assays. We found that knockdown of FABP5 suppressed the proliferation, migration, and invasion of pNEN cell lines, while overexpression of FABP5 had the opposite effect. Co‐immunoprecipitation experiments were performed to clarify the interaction between FABP5 and fatty acid synthase (FASN). We further showed that FABP5 regulates the expression of FASN via the ubiquitin proteasome pathway and both proteins facilitate the progression of pNENs. Our study demonstrated that FABP5 acts as an oncogene by promoting lipid droplet deposition and activating the WNT/β‐catenin signaling pathway. Moreover, the carcinogenic effects of FABP5 can be reversed by orlistat, providing a novel therapeutic intervention option.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Geriatric Gastroenterology, Neuroendocrine Tumor Center, Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Institute of Neuroendocrine Tumor, Nanjing Medical Universit…
Förderung
- Science Foundation Project of Ili & Jiangsu Joint Institute of Health
Zitieren
APA
Lu, F., Ye, M., Hu, C., Chen, J., Yan, L., Gu, D., Xu, L., Tian, Y., Bai, J., & Tang, Q. (2023). FABP5 regulates lipid metabolism to facilitate pancreatic neuroendocrine neoplasms progression via FASN mediated Wnt/β‐catenin pathway. Cancer Science, 114(9), 3553-3567. https://doi.org/10.1111/cas.15883
Vancouver
Lu F, Ye M, Hu C, Chen J, Yan L, Gu D, et al. FABP5 regulates lipid metabolism to facilitate pancreatic neuroendocrine neoplasms progression via FASN mediated Wnt/β‐catenin pathway. Cancer Science. 2023;114(9):3553-3567. doi:10.1111/cas.15883
BibTeX
@article{Lu2023,
author = {Lu, Feiyu and Ye, Mujie and Hu, Chunhua and Chen, Jinhao and Yan, Lijun and Gu, Danyang and Xu, Lin and Tian, Ye and Bai, Jianan and Tang, Qiyun},
title = {FABP5 regulates lipid metabolism to facilitate pancreatic neuroendocrine neoplasms progression via FASN mediated Wnt/β‐catenin pathway},
journal = {Cancer Science},
year = {2023},
volume = {114},
number = {9},
pages = {3553--3567},
doi = {10.1111/cas.15883}
}
EUVIMED